Related Experiment Video

Updated: May 22, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Molecular study of signaling-pathway genes in experimental rat thyroid carcinoma

María Inés Carmona-López1, Manuel De Miguel, Hugo Galera-Ruiz

  • 1Departamento de Citología e Histología Normal y Patológica, Universidad de Sevilla, Sevilla, Spain.

Endocrine Research
|May 29, 2012
PubMed
Abstract

Insights

Goitrogen-induced rat thyroid tumors did not show common human cancer gene mutations (N-ras, B-raf, PI3KCA). However, four new B-raf mutations were found, potentially marking this specific tumor type.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Investigates histological patterns and biomolecular changes in goitrogen-induced experimental rat thyroid tumors.
  • Explores the link between observed histological types and common gene mutations (N-ras, B-raf, PI3KCA) found in human thyroid cancers.

Purpose of the Study:

  • To determine if specific gene mutations (N-ras, B-raf, PI3KCA) are involved in the development of experimental rat thyroid tumors.
  • To analyze biomolecular changes in relation to histological patterns in goitrogen-induced thyroid tumors.

Main Methods:

  • Examined paraffin-embedded thyroid tumor tissue sections from Wistar rats treated with potassium perchlorate (KClO(4)) over 18 months.
  • Extracted DNA and sequenced specific gene regions (N-ras exon 1, PI3KCA exons 9 & 20, B-raf exon 15) to identify mutations.

Main Results:

  • All induced tumors were of the follicular type.
  • No N-ras, B-raf, or PI3KCA mutations typically found in human thyroid cancers were detected in the experimental rat thyroids.
  • Ninety percent of experimental tumors harbored four novel B-raf gene mutations, all of which were silent and did not alter the protein sequence.

Conclusions:

  • N-ras, PI3KCA, and B-raf gene mutations may not play a role in thyroid tumor formation under the experimental conditions used.
  • The identified B-raf mutations, despite lacking functional impact, could serve as a specific marker for this experimental rat thyroid tumor model.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...